Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22


Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.

Safarzadeh E, Hashemzadeh S, Duijf PHG, Mansoori B, Khaze V, Mohammadi A, Kazemi T, Yousefi M, Asadi M, Mohammadi H, Babaie F, Baradaran B.

J Cell Physiol. 2018 Oct 26. doi: 10.1002/jcp.26896. [Epub ahead of print]


Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress.

Lin CY, Beattie A, Baradaran B, Dray E, Duijf PHG.

Sci Rep. 2018 Sep 17;8(1):13904. doi: 10.1038/s41598-018-32272-x.


MicroRNAs in cancer drug resistance: Basic evidence and clinical applications.

Ghasabi M, Mansoori B, Mohammadi A, Duijf PH, Shomali N, Shirafkan N, Mokhtarzadeh A, Baradaran B.

J Cell Physiol. 2018 Aug 26. doi: 10.1002/jcp.26810. [Epub ahead of print] Review.


CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer.

Kalimutho M, Sinha D, Jeffery J, Nones K, Srihari S, Fernando WC, Duijf PH, Vennin C, Raninga P, Nanayakkara D, Mittal D, Saunus JM, Lakhani SR, López JA, Spring KJ, Timpson P, Gabrielli B, Waddell N, Khanna KK.

EMBO Mol Med. 2018 Sep;10(9). pii: e8566. doi: 10.15252/emmm.201708566.


Treating cancer with microRNA replacement therapy: A literature review.

Hosseinahli N, Aghapour M, Duijf PHG, Baradaran B.

J Cell Physiol. 2018 Aug;233(8):5574-5588. doi: 10.1002/jcp.26514. Epub 2018 Mar 9. Review.


Translocation Breakpoints Preferentially Occur in Euchromatin and Acrocentric Chromosomes.

Lin CY, Shukla A, Grady JP, Fink JL, Dray E, Duijf PHG.

Cancers (Basel). 2018 Jan 8;10(1). pii: E13. doi: 10.3390/cancers10010013.


Overexpression of the E2F target gene CENPI promotes chromosome instability and predicts poor prognosis in estrogen receptor-positive breast cancer.

Thangavelu PU, Lin CY, Vaidyanathan S, Nguyen THM, Dray E, Duijf PHG.

Oncotarget. 2017 Jul 10;8(37):62167-62182. doi: 10.18632/oncotarget.19131. eCollection 2017 Sep 22.


Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression.

Shajari N, Davudian S, Kazemi T, Mansoori B, Salehi S, Khaze Shahgoli V, Shanehbandi D, Mohammadi A, Duijf PHG, Baradaran B.

Artif Cells Nanomed Biotechnol. 2018 Nov;46(7):1495-1504. doi: 10.1080/21691401.2017.1374284. Epub 2017 Sep 11.


In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion.

Thangavelu PU, Krenács T, Dray E, Duijf PH.

Clin Epigenetics. 2016 Nov 18;8:120. eCollection 2016.


In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesis.

Vaidyanathan S, Cato K, Tang L, Pavey S, Haass NK, Gabrielli BG, Duijf PH.

Oncogene. 2016 Oct 13;35(41):5446-5455. doi: 10.1038/onc.2016.94. Epub 2016 Apr 11.


The cancer biology of whole-chromosome instability.

Duijf PH, Benezra R.

Oncogene. 2013 Oct;32(40):4727-36. doi: 10.1038/onc.2012.616. Epub 2013 Jan 14. Review.


Cancer cells preferentially lose small chromosomes.

Duijf PH, Schultz N, Benezra R.

Int J Cancer. 2013 May 15;132(10):2316-26. doi: 10.1002/ijc.27924. Epub 2012 Nov 26.


Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition.

Schvartzman JM, Duijf PH, Sotillo R, Coker C, Benezra R.

Cancer Cell. 2011 Jun 14;19(6):701-14. doi: 10.1016/j.ccr.2011.04.017.


A novel translation re-initiation mechanism for the p63 gene revealed by amino-terminal truncating mutations in Rapp-Hodgkin/Hay-Wells-like syndromes.

Rinne T, Clements SE, Lamme E, Duijf PH, Bolat E, Meijer R, Scheffer H, Rosser E, Tan TY, McGrath JA, Schalkwijk J, Brunner HG, Zhou H, van Bokhoven H.

Hum Mol Genet. 2008 Jul 1;17(13):1968-77. doi: 10.1093/hmg/ddn094. Epub 2008 Mar 25.


Mutations in the human TBX4 gene cause small patella syndrome.

Bongers EM, Duijf PH, van Beersum SE, Schoots J, Van Kampen A, Burckhardt A, Hamel BC, Losan F, Hoefsloot LH, Yntema HG, Knoers NV, van Bokhoven H.

Am J Hum Genet. 2004 Jun;74(6):1239-48. Epub 2004 Apr 21.


Pathogenesis of split-hand/split-foot malformation.

Duijf PH, van Bokhoven H, Brunner HG.

Hum Mol Genet. 2003 Apr 1;12 Spec No 1:R51-60. Review.


Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.

Ghioni P, Bolognese F, Duijf PH, Van Bokhoven H, Mantovani R, Guerrini L.

Mol Cell Biol. 2002 Dec;22(24):8659-68.


A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism.

Serber Z, Lai HC, Yang A, Ou HD, Sigal MS, Kelly AE, Darimont BD, Duijf PH, Van Bokhoven H, McKeon F, Dötsch V.

Mol Cell Biol. 2002 Dec;22(24):8601-11.


Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63.

Duijf PH, Vanmolkot KR, Propping P, Friedl W, Krieger E, McKeon F, Dötsch V, Brunner HG, van Bokhoven H.

Hum Mol Genet. 2002 Apr 1;11(7):799-804.


p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation.

van Bokhoven H, Hamel BC, Bamshad M, Sangiorgi E, Gurrieri F, Duijf PH, Vanmolkot KR, van Beusekom E, van Beersum SE, Celli J, Merkx GF, Tenconi R, Fryns JP, Verloes A, Newbury-Ecob RA, Raas-Rotschild A, Majewski F, Beemer FA, Janecke A, Chitayat D, Crisponi G, Kayserili H, Yates JR, Neri G, Brunner HG.

Am J Hum Genet. 2001 Sep;69(3):481-92. Epub 2001 Jul 17.


Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63.

McGrath JA, Duijf PH, Doetsch V, Irvine AD, de Waal R, Vanmolkot KR, Wessagowit V, Kelly A, Atherton DJ, Griffiths WA, Orlow SJ, van Haeringen A, Ausems MG, Yang A, McKeon F, Bamshad MA, Brunner HG, Hamel BC, van Bokhoven H.

Hum Mol Genet. 2001 Feb 1;10(3):221-9.


Supplemental Content

Loading ...
Support Center